formulations

6th Nov’20 – Sep’20 earnings update on Suven Pharma and Can Fin Homes

Dear Members, We have released 6th Nov’20 – Sep’20 earnings update on Suven Pharmaceuticals and Can Fin Homes. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 6th Nov’20   Suven Pharmaceuticals (NSE – SUVENPHAR) – May’17 Alpha stock CMP – 325.75 (BSE); 326.60 (NSE) Rating – Positive – 5% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Suven Pharmaceuticals got demerged from Suven Lifesciences with the entire revenue generating businesses consisting of CRAMS,…

Read More

21st Aug’20 – Jun’20 earnings update on Chaman Lal and Suven Pharma

Dear Members, We have released 21st Aug’20 – Jun’20 earnings update on Chaman Lal Setia and Suven Pharmaceuticals. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 21st Aug’20   Chaman Lal Setia (BSE – 530307) – Sep’19 Alpha stock CMP – 99.85 (BSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Chaman Lal has reported good set of numbers for the quarter ending…

Read More
Copy Protected by Chetan's WP-Copyprotect.